Ethical issues surrounding the evaluation of oxidative phosphorylation disorders in children

N Krawiecki1

  • 1Emory University School of Medicine, Scottish Rite Molecular Medicine Laboratory, Children's Healthcare of Atlanta, Atlanta, Georgia 30342-1600, USA.

Seminars in Neurology
|October 20, 2001
PubMed

Insights

Genetic testing for pediatric neurological issues is rising. Ethical considerations for oxidative phosphorylation disorders involve informed consent, patient autonomy, and genetic privacy.

Area of Science:

  • Pediatric Genetics
  • Mitochondrial Diseases
  • Bioethics

Background:

  • Genetic testing is increasingly used in pediatric evaluations.
  • Oxidative phosphorylation disorders are a growing consideration for undiagnosed pediatric neurological problems.
  • These disorders have complex genetic control involving nuclear and mitochondrial DNA.

Purpose of the Study:

  • To explore the ethical issues arising from genetic testing for oxidative phosphorylation disorders in children.
  • To emphasize the importance of informed consent, patient autonomy, and family-centered care.
  • To address concerns regarding genetic discrimination and privacy laws.

Main Methods:

  • Literature review on genetic testing in pediatrics.
  • Analysis of ethical frameworks for genetic disorders.
  • Case study review of pediatric neurological cases with suspected oxidative phosphorylation disorders.

Main Results:

  • Genetic testing complexity necessitates careful ethical navigation.
  • Informed consent requires clear communication about dual genetic origins (nuclear and mitochondrial DNA).
  • Balancing patient/family interests with diagnostic procedures is crucial.

Conclusions:

  • Open communication is paramount in pediatric genetic medicine.
  • Ethical challenges in genetic testing require proactive management.
  • Upholding patient autonomy and privacy is essential when diagnosing mitochondrial disorders.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...
Electron Transport Chain: Complex III and IV01:43

Electron Transport Chain: Complex III and IV

During the electron transport chain, electrons from NADH and FADH2 are first transferred to complexes I and II, respectively. These two complexes then transfer the electrons to ubiquinol, which carries them further to complex III. Complex III passes the electrons across the intermembrane space to Cyt c, which carries them further to complex IV. Complex IV donates electrons to oxygen and reduces it to water. As electrons pass through complexes I, III, and IV, the energy released aids the pumping...